Evaluation for Clinical Efficacy of Anatomical Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia with Underactive bladder

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Aged 60-80 years, men;
•2. Diagnosis of benign prostatic obstruction; Urodynamics suggest weak or no contraction of the detrusor(BCI<100 or Pdet@Qmax<40cmH2O)
•3. With any of the following conditions:
•(1) The International Prostate Symptom Score (IPSS>=12), and the quality of life score (QOL)>=4 points;
•(2) The maximum urinary flow rate (Qmax) is less than 15ml/s (>=150ml);
•(3) The effect of drug treatment is not good;
•(4) The recurrent urinary retention (more than once);
•4. Subject is classified ASA I, II, or III;
•5. The patient agreed to participate in this trial, and signed informed consent.

•1. There is operation contraindications of transurethral prostatic hyperplasia resection;
•2. Subject has a life expectancy <2 yr;
•3. Subject is currently enrolled in or plans to enrol in any other study;
•4. Subject has a Normal detrusor contractility;
•5. Subject has diagnosis of stress urinary incontinence that requires treatment or daily pad or device use;
•6. Subject has history urethral stricture or bladder neck contracture within the last 6 months;
•7. Subject has history of lower urinary tract surgery;
•8. Subject has diagnosis of prostate cancer;
•9. Combined with advanced malignant tumor or chronic wasting disease;
•10. Combined with serious heart,lung disease or severe mental disorder;
•11. Has an active infection;
•12. Subject has a disorder of the coagulation cascade or disorders that affect platelet count or function;
•13. Can not finished the follow-up for poor compliance.

发起方

Guangdong Provincial Hospital of Chinese Medicine